CERVINO
A Phase 3, Multicenter, Randomized, Open Label Study of Etentamig Compared With Standard Available Therapies in Subjects With Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)
Near Add Your Location
Sorting 43 by
Medical University of South Carolina
Charleston, SC
- Accepting patients
- Accepting patients
- Accepting patients
University of Illinois at Chicago
Chicago, IL
- Accepting patients
- Accepting patients
Rocky Mountain Cancer Centers - Sky Ridge Medical Center (Lone Tree)
Lone Tree - Skyridge
Lone Tree, CO
- Accepting patients
Texas Oncology
Tyler, TX
- Accepting patients
Cancer Specialists of North Florida - Southpoint
Jacksonville, FL
- Accepting patients
Mayo Clinic (Arizona)
Phoenix, AZ
- Accepting patients
Providence St. Jude Medical Center
Fullerton, CA
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.